Gene Expression That Predicts Radiation Exposure in Humans

NCT03123133 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 151

Last updated 2021-04-21

No results posted yet for this study

Summary

To verify and validate a biodosimetry test for determining absorbed ionizing radiation dose by analyzing gene expression signatures of blood samples collected from patients treated with Total Body Irradiation (TBI).

Conditions

  • Total Body Irradiation

Sponsors & Collaborators

Principal Investigators

  • Aviva Jacobs, PhD · Director, Product Developement

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-06
Primary Completion
2020-04-17
Completion
2020-07-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03123133 on ClinicalTrials.gov